Login

u/ExtremeLeather7705

r/DTIC
▲ 67 r/DTIC

Upgraded price targets from this morning - many upgrades!!!

Robert W. Baird raised Definium Therapeutics’ price target to $75 from $57 and maintained an “outperform” rating.

In a report released today, Wells Fargo reiterated a Buy rating on Definium Therapeutics, with a price target of $72.00.

Canaccord Genuity maintained a Buy rating on Definium Therapeutics, with a price target of $64.00

RBC maintained a Buy rating on Definium Therapeutics yesterday and set a price target of $66.00.

JonesTrading reiterated a Buy rating on Definium Therapeutics, with a price target of $90.00.

Add more below if you stumble across them today.

🚀

reddit.com
u/ExtremeLeather7705 — 7 days ago
▲ 60 r/DTIC

Evercore ISI analyst Gavin Clark-Gartner models $2 billion in peak annual sales of DT120 for generalized anxiety disorder, plus $2 billion from major depression and $1 billion from PTSD.

biopharmadive.com
u/ExtremeLeather7705 — 8 days ago
▲ 30 r/DTIC

5day Cup and Handle - about as bullish as it gets

Load up now - this company is a 🚀
The world has never seen a therapy like this before

u/ExtremeLeather7705 — 3 months ago